National Center for Disease Control and

In any case, injection site responses (erythemia, edema, pain, and tenderness) and systemic responses are both evaluated in subjects (Mathieu, 1997). USFDA also has specific guidance on the tracking and reporting of adverse clinical responses to vaccines. Any adverse events or product problems with vaccines should not be sent to MedWatch but to the Vaccine Adverse Event Reporting System (VAERA), operated jointly by FDA and the national Centers for Disease Control and Prevention. For a copy of the VAERS form, call 1-800-822-7967, or download the form (in PDF format) from www.fda.gov/cber/vaers/vaersl.pdf on FDA s Website. 

National Center for Disease Control and Public Health and Medical Statistics of Georgia, Tbilisi, Georgia... 

The Registry of the Effects of Toxic Substances, Department of Health, Education and Welfare, PubHc Health Services, Center for Disease Control, and the National Institute for Occupational Safety and Health, Washington, D.C., 1977, updated quarterly. 

Centers for Disease Control and Prevention and National Institutes of Health. Primary Containment of Biohazards Selection, Installation and Use of Biological Safety Cabinets. Washington, DC U.S. Department of Health and Human Services, 1995 (available on http // www.niehs.nih.gov/odhsb/biosafe/bsc/bsc.htm)... 

A document from the U.S. Centers for Disease Control and Prevention and National Institutes of Health" describes, in detail, the different BSC designs and operating parameters. This document is easily available on the Internet and only a short summary will be provided here. For more detail regarding operation, design, use, testing, protection, etc. the reader is referred to the latest edition of the CDC-NIH document. 

The Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety surveillance program co-sponsored by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). VAERS collects and analyzes information from reports of adverse reactions after immunization. Anyone can report to VAERS, and reports are sent in by vaccine manufacturers, health care providers, and vaccine recipients and their parents or guardians. An example of the VAERS and instructions for completing the form are found in Appendix F. Any clinically significant adverse event that occurs after the administration of any vaccine should be reported. Individuals are encouraged to provide the information on the form even if the individual is uncertain if the event was related to the... 

NIOSH. 1995. Report to Congress on Workers Home Contamination Study conducted under the workers family protection act (29 U.S.C.671a). U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention. National Institute for Occupational Safety and Health. September 1995. 

The Environmental Health Laboratory Sciences Division of the National Center for Environmental Health, Centers for Disease Control and Prevention, is developing methods for the analysis of trichloroethylene and other volatile organic compounds in blood. These methods use purge and trap methodology, high resolution... 

Centers for Disease Control and Prevention (2001). National Report on Human Exposure to Environmental Chemicals. Atlanta, Georgia. 

Brown, D.F., A.J. Policastro, W.E. Dunn, R. A. Carhart, M. A. Lazaro, W. A. Freeman, and M. Krumpolc. Development of the Table of Initial Isolation and Protective Action Distances for the 2000 Emergency Response Guidebook, Argonne National Laboratory Report No. ANL/DIS-00-1. October 2000. Buckles, L.C. and S.M. Lewis. "S-(2-Diisopropylamino-ethyl)0-ethyl methylphosphonothioate Stabilized with Soluble Carbodiimides," United States Patent 4012464, September 24,1965. Centers for Disease Control and Prevention. "Case Definition Nerve Agents or Organophosphates." March 15,2005. 

From Panel on Clinical Practices for the Treatment of HIV Infection. Treating Opportunistic Infections among HIV-Infected Adults and Adolescents recommendations from Center for Disease Control and Prevention, the National Institutes of Health and the HIV Medicine Association/lnfedious Diseases Society of America. December 17, 2004, http //mm.AIDSinfo.NIH.gov. 

Biostatistics and Epidemiology Branch Health Effects Laboratory Division National Institute for Occupational Safety and Health Centers for Disease Control and Prevention... 

Microbiological and Biomedical Laboratories, jointly produced by the U.S. Department of Health and Human Services/Public Health Service, the Center for Disease Control and Prevention, and the National Institutes of Health. This procedure is finely written, but sometimes not followed in practice. The 4th ed., May, 1999, quoted here is available by contacting the Government Printing Office, Washington, D.C (priced at 12.00 per copy in 1999). 

---